Clinical Features of Type 1 & 2 Diabetes Flashcards

1
Q

Epidemiology of Type 2 Diabetes

A
  • Most common form of diabetes
  • 85% of all diabetes in Caucasian populations
  • 95% of all diabetes in other ethnic groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for Type 2 Diabetes?

A
-Genetics
=Race
-Increasing age
-Central obesity
-Low birth weight (hypertension and heart disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the genetic component of Type 2 Diabetes

A
  • Genome-wide association studies have identified >400 gene variants associated with an increased risk of Type 2 diabetes= polygenic
  • Most relate to beta cell function or mass, rather than obesity/insulin resistance
  • 40% of the overall risk of Type 2 diabetes is determined by genetic factors
  • Relative with Type 2 Diabetes= x5 risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the prevalence of Type 2 Diabetes

A
  • More than 25% of people of Asian origin aged>60 years suffer from diabetes (greater in all age groups than European)
  • Massively different between ethnicities (genetically- code for central obesity, smaller pancreas, less beta cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why does incidence and prevalence of Type 2 Diabetes increase with age?

A
  • Beta cell function reduces with age

- Obesity increases with age (lower age on onset in more overweight people)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the stages of development of Type 2 Diabetes?

A
  • Normal glucose tolerance
  • Impaired glucose metabolism (insulin secretion 150%)
  • Impaired glucose tolerance (50% tolerance)
  • Type 2 Diabetes (secretion= 50%, tolerance= 70%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the classical presentation of Type 2 Diabetes?

A
  • Asymptomatic – found on routine screening
  • Thirst (hypothalamus, leads to polydipsia), polyuria (osmotic symptoms= glucose in urine)
  • Malaise, chronic fatigue
  • Infections, e.g. thrush (candidiasis, skin infection, UTI); boils (sugary environment)
  • Blurred vision (lens in eyes coated in glucose= osmotic drag for interstitial fluid= refractive error as lens distorted)
  • Complication as presenting problem (e.g. retinopathy, neuropathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the features of metabolic syndrome?

A

-Central obesity
-High blood pressure
-High triglycerides
-Low HDL-cholesterol
=very atherogenic
-Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What other medical disorders are associated with Type 2 Diabetes?

A
  • Obstructive Sleep Apnoea
  • Polycystic Ovarian Disease
  • Hypogonadotropic Hypogonadism in men (testosterone levels drop more quickly, adipose inhibits trophin, more aromatase)
  • Non-Alcoholic Fatty Liver Disease= cirrhosis and hepatocellular carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the symptoms of Type 1 Diabetes at presentation?

A
  • Polyuria, thirst
  • Fatigue, malaise
  • Weight loss
  • Blurred vision
  • Nausea, vomiting
  • Usual presentation is in childhood, adolescence or young adulthood
  • Can present at any age, more acute onset
  • Short history (weeks) of florid osmotic symptoms and rapid weight loss; Ketonuria/ketonaemia is usually present
  • High risk of metabolic decompensation - ketoacidosis (insulin deficiency= less glucose in cells= generate ketones= acidic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the pathogenesis of Type 1 Diabetes

A

-Genetic predisposition – HLA haplotypes (HLA-DR and HLA-DQ) as risk alleles
-Environmental trigger
=? viral infection
=? chemical toxin
-Autoimmune mechanism activated – can detect antibodies in blood to GAD, IA2 and/or ZnT8
-Destruction of pancreatic beta cells (cytotoxic lymphocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the development of Type 1 Diabetes

A

-Progressive destruction beta cells
-Can take many years
=Genetic susceptibility
=Insulitis, inflammatory cell infiltration
=Impaired glucose tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the relative risk when relatives are diagnosed with Type 1 Diabetes?

A
  • 0.5% lifetime risk
  • Father= 9
  • Mother= 3
  • Non-HLA identical sibling= 3
  • HLA-identical sibling= 16
  • Non-identical twin= 20
  • Identical twin= 35%
  • Bother parents= 30%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the prevalence of Type 1 Diabetes

A

-North-South Gradient in Europe
= More cases the further north
=Viruses in cold climates??

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What autoimmune disorders are associated with Diabetes?

A
  • Thyroid disease
  • Pernicious anaemia
  • Coeliac disease
  • Addison’s disease
  • Vitiligo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the consequences on daily life by having Type 1 Diabetes?

A
-Hypoglycaemia
=Driving
=Employment
-Risks of Diabetic Ketoacidosis
-Pregnancy (risk of miscarriage, big baby, foetal abnormality due to hyperglycaemia)
-Childhood and adolescence
-Complications
17
Q

Causes of secondary diabetes

A

-Exocrine Pancreas Disorders
=Pancreatectomy
=Trauma (chronic pancreatitis, cystic fibrosis)
=Tumours
-Endocrinopathies
-Drugs (steroid, glucocorticoid treatments)

18
Q

What is MODY?

A
-Maturity-Onset Diabetes of the Young
=Early-onset diabetes
=Not insulin-dependent diabetes
=Autosomal dominant inheritance
=Obesity unusual
=Caused by a single gene defect altering beta-cell function (monogenic)
=1-2% of ‘Type 2’ diabetes
19
Q

Describe the genetics of MODY

A

-MODY2/ Glucokinase (14%)
-Transcription factors (75%)
=Responds to sulphonyl urea therapy
-MODYX (11%)
*tailor treatment for genetic defect

20
Q

Describe Home Blood Glucose Monitoring

A

-Demonstrates glucose control throughout day (and night)
-Identifies hypoglycaemia (especially when asymptomatic)
-Provides information to adjust insulin dose
-Allows manipulation of insulin dose during
=intercurrent illness
=travel, sport, other activities
-Assists self-control of diabetes – improves glycaemic control

21
Q

What is CGMS?

A

-Continuous Glucose Monitoring System
-Wireless sensor and monitor communication
-Hypo- and hyperglycaemic alarms
=reveals glycaemic variability, risk factor of diabetic complication development
-Real time glucose values

22
Q

Describe HbA1c as a monitoring tool

A

-Checked at the time of a visit to a diabetes clinic or GP surgery
-Allows evaluation of :
=efficacy of therapeutic regimen
=patient’s adherence to treatment
=risk of developing diabetic complications
-Enhances clinical decision-making if available at time of clinical consultation